JOHNSON & JOHNSON

Products

Category

Product

Brand

Description

Global Markets for Infectious Disease Treatments (PHM061F)

Edurant (rilpivirine)		Non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretroviral agents to treat HIV-1 infection in certain adults and pediatric patients. It works by blocking the reverse transcriptase enzyme, which the virus needs to replicate, helping to reduce the viral load in the body.
Prezista (darunavir)		Protease inhibitor used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and children. It works by inhibiting the HIV protease enzyme, preventing the virus from maturing and multiplying, thereby helping to lower the viral load and improve immune function.
Prezcobix/Rezolsta (darunavir/cobicistat)		Protease inhibitor used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and children.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment